UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.878

Sortiert nach

Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)

Leukemia, 2015-04, Vol.29 (4), p.886-894

2015

Volltextzugriff (PDF)

A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy

Leukemia, 2024-08, Vol.38 (8), p.1663-1666

2024

Volltextzugriff (PDF)

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

Bone marrow transplantation (Basingstoke), 2012-02, Vol.47 (2), p.203-211

2012

Volltextzugriff (PDF)

To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century

Bone marrow transplantation (Basingstoke), 2013-11, Vol.48 (12), p.1497-1505

2013

Volltextzugriff (PDF)

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

Bone marrow transplantation (Basingstoke), 2007-10, Vol.40 (8), p.709-719

2007

Volltextzugriff (PDF)

Donor lymphocyte infusions: the long and winding road: how should it be traveled?

Bone marrow transplantation (Basingstoke), 2008-11, Vol.42 (9), p.569-579

2008

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

Bone marrow transplantation (Basingstoke), 2014-11, Vol.49 (11), p.1360-1365

2014

Volltextzugriff (PDF)

Not too little, not too much—just right! (Better ways to give high dose melphalan)

Bone marrow transplantation (Basingstoke), 2014-12, Vol.49 (12), p.1457-1465

2014

Volltextzugriff (PDF)

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies

Leukemia, 2015-08, Vol.29 (8), p.1754-1762

2015

Volltextzugriff (PDF)

Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?

Bone marrow transplantation (Basingstoke), 2014-01, Vol.49 (1), p.1-7

2014

Volltextzugriff (PDF)

Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic?

Bone marrow transplantation (Basingstoke), 2013-07, Vol.48 (7), p.884-889

2013

Volltextzugriff (PDF)

Impact of early CMV reactivation in cord blood stem cell recipients in the current era

Bone marrow transplantation (Basingstoke), 2016-08, Vol.51 (8), p.1113-1120

2016

Volltextzugriff (PDF)

Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?

Bone marrow transplantation (Basingstoke), 2006-07, Vol.38 (1), p.7-15

2006

Volltextzugriff (PDF)

Iron overload in hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2008-06, Vol.41 (12), p.997-1003

2008

Volltextzugriff (PDF)

Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?

Bone marrow transplantation (Basingstoke), 2007-05, Vol.39 (10), p.577-588

2007

Volltextzugriff (PDF)

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

Bone marrow transplantation (Basingstoke), 2016-02, Vol.51 (2), p.277-282

2016

Volltextzugriff (PDF)

Immune restoration following hematopoietic stem cell transplantation: an evolving target

Bone marrow transplantation (Basingstoke), 2005-05, Vol.35 (9), p.835-857

2005

Volltextzugriff (PDF)

Renal allografts in plasma cell myeloma hematopoietic cell graft recipients: on the verge of an explosion?

Bone marrow transplantation (Basingstoke), 2013-03, Vol.48 (3), p.338-345

2013

Volltextzugriff (PDF)

Chronic graft-versus-host disease: clinical manifestation and therapy

Bone marrow transplantation (Basingstoke), 2001-07, Vol.28 (2), p.121-129

2001

Volltextzugriff (PDF)

Clostridium difficile-associated disease in human stem cell transplant récipients : coming epidemic or false alarm?

Bone marrow transplantation (Basingstoke), 2008-12, Vol.42 (11), p.705-713

2008

Volltextzugriff (PDF)

Trimming the fat: obesity and hematopoietic cell transplantation

Bone marrow transplantation (Basingstoke), 2013-09, Vol.48 (9), p.1152-1160

2013

Volltextzugriff (PDF)

Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies

Bone marrow transplantation (Basingstoke), 2012-07, Vol.47 (7), p.924-933

2012

Volltextzugriff (PDF)

Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy

Journal of clinical oncology, 2000-01, Vol.18 (2), p.307-316

2000

Volltextzugriff (PDF)

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)

Bone marrow transplantation (Basingstoke), 2002-08, Vol.30 (4), p.215-222

2002

Volltextzugriff (PDF)

High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR

Bone marrow transplantation (Basingstoke), 2011-03, Vol.46 (3), p.385-392

2011

Volltextzugriff (PDF)

1 – 25 von 1.878

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.582)
Mit Volltextzugriff
(1.603)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(9)

Menü

Weitere Dienste

Einstellungen

Immunosuppressive therapy of LGL leukemia: prospective multicenter phase II study by the Eastern Cooperative Oncology Group (E5998)

A modest proposal to the transplant publik to prevent harm to people with acute myeloid leukaemia in 1st complete remission cured by chemotherapy

Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS

To transplant or not: a dilemma for treatment of elderly AML patients in the twenty-first century

Diagnosis and treatment of transplantation-associated thrombotic microangiopathy: real progress or are we still waiting?

Donor lymphocyte infusions: the long and winding road: how should it be traveled?

Allogeneic hematopoietic cell transplantation for mycosis fungoides and Sezary syndrome

Not too little, not too much—just right! (Better ways to give high dose melphalan)

Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies

Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?

Umbilical cord blood graft enhancement strategies: has the time come to move these into the clinic?

Impact of early CMV reactivation in cord blood stem cell recipients in the current era

Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted?

Iron overload in hematopoietic cell transplantation

Mobilizing stem cells from normal donors: is it possible to improve upon G-CSF?

Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis

Immune restoration following hematopoietic stem cell transplantation: an evolving target

Renal allografts in plasma cell myeloma hematopoietic cell graft recipients: on the verge of an explosion?

Chronic graft-versus-host disease: clinical manifestation and therapy

Clostridium difficile-associated disease in human stem cell transplant récipients : coming epidemic or false alarm?

Trimming the fat: obesity and hematopoietic cell transplantation

Prospective study of one- vs two-unit umbilical cord blood transplantation following reduced intensity conditioning in adults with hematological malignancies

Rapid Hematopoietic Recovery After Coinfusion of Autologous-Blood Stem Cells and Culture-Expanded Marrow Mesenchymal Stem Cells in Advanced Breast Cancer Patients Receiving High-Dose Chemotherapy

Allogeneic mesenchymal stem cell infusion for treatment of metachromatic leukodystrophy (MLD) and Hurler syndrome (MPS-IH)

High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR

Suchergebnisse filtern